Sublimed

SUBLIMED is a start-up healthcare company that develops medical devices for managing chronic pain. Our mission is to closely work with patients and healthcare professionals to offer innovations adapted to the treatment and the daily life of chronic pain patients. SUBLIMED products are under prescription only. SUBLIMED was founded in October 2015 as a spinoff from the CEA (Commissariat à l’Energie Atomique). The founding team involved Nicolas Karst, PhD and Jean-Pierre Alibeu, M.D. , former Chief of Department of the Pain Centre at the University Hospital Centre in Grenoble. In June 2016, SUBLIMED finalized its first round of fund-raising, obtaining more than €700 K from three investment funds. SUBLIMED obtained IS0 13485 certification awarded by the BSI notified body as well as CE marking for its first medical device actiTENS in February 2018. actiTENS is a compact, ergonomic and connected new-generation transcutaneous electrical nerve stimulator (TENS).